Leaflet UGUROL 500mg / 5ml solution for injection for intravenous, oral and cutaneous administration
- Product code:
- W68079001
- Quantity:
- 6
- Indicated for:
- bleeding; coagulation disorders
- Route of administration:
- injectable / oral / cutaneous
- Substance:
- tranexamic acid (antifibrinolytic)
- ATC
- B02AA02 — Blood and blood forming organs | Antifibrinolytics | Amino acids
Tranexamic acid is an antifibrinolytic agent used to prevent and treat excessive bleeding caused by increased fibrinolysis, a process in which blood clots dissolve too quickly. It works by inhibiting plasminogen, thereby reducing fibrin degradation and helping to stabilize blood clots.
It is used for the treatment of heavy menstrual bleeding (menorrhagia), postoperative hemorrhages, severe trauma, and hemophilia. It is also administered in postpartum hemorrhage to reduce the risk of severe complications.
Tranexamic acid can be given orally, intravenously, or topically, depending on the medical indication. It is preferred for its relatively high safety profile and effectiveness in reducing blood loss without significantly increasing the risk of thrombosis.
Side effects include nausea, diarrhea, headache, and, in rare cases, severe allergic reactions or thrombotic events. It is not recommended for patients with a history of thromboembolism without close medical supervision.
It is used for the treatment of heavy menstrual bleeding (menorrhagia), postoperative hemorrhages, severe trauma, and hemophilia. It is also administered in postpartum hemorrhage to reduce the risk of severe complications.
Tranexamic acid can be given orally, intravenously, or topically, depending on the medical indication. It is preferred for its relatively high safety profile and effectiveness in reducing blood loss without significantly increasing the risk of thrombosis.
Side effects include nausea, diarrhea, headache, and, in rare cases, severe allergic reactions or thrombotic events. It is not recommended for patients with a history of thromboembolism without close medical supervision.
General data about UGUROL 500mg / 5ml
- Substance:
- tranexamic acid
- Date of latest medicines list:
- 01-02-2024
- Product code:
- W68079001
- Concentration:
- 500mg / 5ml
- Pharmaceutical form:
- solution for injection for intravenous, oral and cutaneous administration
- Quantity:
- 6
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for tranexamic acid
Concentrations available for tranexamic acid
- 0.5g/5ml
- 1000mg
- 100mg/ml
- 10mg/ml
- 500mg
- 500mg/5ml